# Molina Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2020

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-K
- Filed: 2021-02-16
- Accepted by EDGAR: Feb 16, 2021, 09:05 ET
- Period: 2020-12-31
- Accession: 0001179929-21-000024
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992921000024/moh-20201231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992921000024/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | $19.42bn | us-gaap:Revenues |
| Gross profit | 12 months, 2020-01-01 to 2020-12-31 | $2.48bn | us-gaap:GrossProfit |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | $1.08bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2020-01-01 to 2020-12-31 | $102.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | $288.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | $673.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2020-01-01 to 2020-12-31 | $11.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2020-01-01 to 2020-12-31 | $11.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2020-01-01 to 2020-12-31 | 59,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | $1.89bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $74.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2020-01-01 to 2020-12-31 | $606.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-12-31 | $4.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $7.88bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $9.53bn | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $4.96bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $7.44bn | us-gaap:Liabilities |
| Long-term debt | at 2020-12-31 | $2.13bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-12-31 | $2.10bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992921000024/moh-20201231.htm

Filed Feb 16, 2021.
Source: SEC EDGAR, the filing index for accession 0001179929-21-000024. Last ingested by Listed: Nov 15, 2026, 00:39 ET. No prices; not investment advice.
